Document:

EXHIBIT 4.7

CERTIFICATE OF DESIGNATION

FOR

8% SERIES B CONVERTIBLE REDEEMABLE PREFERRED STOCK

Par value $.001

OF

VYCOR MEDICAL, INC.

          Heather N.
Vinas and Kenneth T. Coviello certify that they are the President and Secretary
of Vycor Medical, Inc., a Delaware corporation (the “Company”); that, pursuant
to the Company’s Certificate of Incorporation and Section 151(g) of the
Delaware General Corporation Law, the Board of Directors of the Company adopted
the following resolutions effective December 21, 2009; and that none of the 8%
Series B Convertible Redeemable Preferred Stock referred to in this Certificate
of Designation has been issued.

1. Creation of 8% Series B Convertible
Redeemable Preferred Stock; Rank. 

There is hereby created a series of preferred stock consisting of
1,000,000 shares and designated as 8% Series B Convertible Redeemable Preferred
Stock, par value $.001 (the “Series B Preferred Stock”), having the voting
rights, powers, preferences, and relative participating, optional and other
special rights, qualifications, limitations and restrictions that are set forth
below. The original issue price (the “Original Issue Price”) of each share of
Series B Preferred Stock shall be $1.00.
The Series B Preferred Stock shall, with respect to dividend rights and rights
upon liquidation, winding up or dissolution, rank (1) junior to any other class
or series of preferred stock hereafter duly established by the Board of
Directors of the Corporation. the terms of which shall specifically provide that
such class or series shall rank prior to the Series B Preferred Stock as to the
payment of dividends or upon distribution of assets upon liquidation, winding
up or dissolution (the “Senior Preferred Stock”), (2) pari passu with any other
class or series of preferred stock hereafter duly established by the Board of
Directors of the Corporation, the terms of which shall specifically provide
that such class or series shall rank pari passu with the Series B Preferred
Stock as to the payment of dividends or upon distribution of assets upon
liquidation, winding up or dissolution (the “Parity Preferred Stock”) and (3)
prior to any other class or series of preferred stock or other class or series
of capital stock of or other equity interests in the Corporation, including,
without limitation, all classes of the Common Stock of the Corporation, whether
now existing or hereafter created (all of such classes: or series of capital
stock and other equity interests of the Corporation, including, without
limitation, the Common. Stock, are collectively referred to herein as the
“Junior Securities”). 

2. Dividends.

          A. Right
to Receive Dividends. Each share of Series B Preferred Stock shall be
entitled to receive, cumulative annual dividends at the rate of 8.0% per annum
on the “Stated Value” thereof. Such dividends shall be due and payable annually
on each anniversary date of an issuance the Series B Preferred Stock (the
“Dividend Payment Date”) in, at the sole and

 exclusive option of the Corporation: (i) cash; or (ii) a number of
shares of the Company’s fully paid and non-assessable Common Stock equal to the
amount of the dividend payment divided by $0.0125 (the “Dividend Shares”). The
Dividend Shares so payable will be paid to the person in whose name the applicable
shares of Series B (or one or more predecessor shares) are registered on the
records of the Corporation (the “Series B Preferred Stock Register” ). Upon
delivery of the Dividend Shares, the Company shall deliver a written notice to
the recipient of any such shares setting forth the calculation of the Dividend
Shares. Stated Value shall mean $1.00 per share of Series B Preferred Stock.

          B. Participation
with Common Stock. In the event the Board of Directors of the Corporation
shall elect to pay or declare and set apart for payment any dividend on any
shares of Common Stock in cash out of funds legally available therefor or in
stock or other consideration, the holders of the Series B Preferred Stock shall
be entitled to receive, before any dividend shall be declared and paid or set
aside for the Common Stock, a dividend per share of Series B Preferred Stock
equal to the per share amount, and in the same form as, the dividend payable to
the holders of the Common Stock.

          C. Dividend
Preference. Dividends, if any, payable to holders of the Series B Preferred
Stock pursuant to Sections 2(A) and 2(B) shall be payable before any dividends
or distributions or other payments shall be paid or set aside for payment upon
the Junior Securities. If there shall be outstanding shares of any Parity
Preferred Stock, no full dividends shall be declared or paid or set apart for
payment on any such securities unless dividends have been or contemporaneously
are ratably declared and paid or declared and a sum sufficient for the payment
thereof set apart for such payment on the Series B Preferred Stock.

3. Liquidation Preference. 

In the event of any liquidation, dissolution, or winding up of the
Corporation, either voluntary or involuntary, distributions to the stockholders
of the Corporation shall be made in. the following manner:

          A. Series
B Preferred Stock Preference. With respect to such liquidation, dissolution
or winding up, the holders of Series B Preferred Stock shall be entitled to
receive, prior and in preference to any distribution of any of the assets or
surplus funds of the Corporation to the holders of Junior Securities but after
distribution of such assets among, or payment thereof to holders of any Senior
Preferred Stock, an amount equal to the Series B Original Issue Price for each
share of Series B Preferred Stock plus an amount equal to all declared but
unpaid dividends on Series B Preferred Stock (the “Series B Liquidation
Preference”).

          B. Distributions.
After the payment of the full Series B Liquidation Preference as set forth in
Section 3(A), the remaining assets of the Corporation legally available for
distribution, if any, shall be distributed ratably to the holders of the Junior
Securities and Common Stock in. an amount equal to the Series B Liquidation
Preference; after such distribution to the holders of the Series B Preferred
Stock and Common Stock, the remaining 

- 2 -

assets of the Corporation legally available for distribution, if any,
shall be distributed ratably (subject to Section 3(C)) among the holders of
Series B Preferred Stock, Series B Preferred Stock and the Common Stock.

          C. Proportionate
Payments. If the assets and funds legally available for distribution among
the holders of Series B Preferred Stock shall be insufficient to permit the
payment to the holders of the full Series B Liquidation Preference, then the
assets and funds shall be distributed ratably among holders of Series B
Preferred Stock in proportion to the number of shares of Series B Preferred
Stock owned by each holder. 

          D. Reorganization
or Merger. A merger or reorganization of the Corporation with or into any
other corporation or corporations or a sale of all or substantially all of the
assets or outstanding capital stock of the Corporation, in which transaction
the Corporation’s stockholders immediately prior to such transaction own
immediately after such transaction less than 50% of the equity securities of
the surviving corporation or its parent, shall be deemed to be a liquidation
within the meaning of this Section 3 and the proceeds payable in such
transaction shall be divided among the stockholders in accordance with this
Section 3.

4. Conversion.

          A. The
Holders of any shares of Series B Preferred Stock may, at such holder’s option,
without any further consideration, at any time, subject to the limitations set
forth herein, elect to convert all or any portion of the shares of Series B
Preferred Stock held by such person, together with any and all accrued and unpaid
dividends, into a number of fully paid and nonassessable shares of Common Stock
equal to the sum of the Stated Value of the Series B Preferred Stock being
converted plus the amount of any accrued and unpaid dividends multiplied by
eighty (80) (the “Conversion Rate”). In the event of a liquidation, dissolution
or winding up of the Company, the Conversion Rights shall terminate at the
close of business on the last full day preceding the date fixed for the payment
of any such amounts distributable on such event to the holders of Series B

          B. In the
event of any conversion resulting in fractional shares, in lieu of issuance of
fractional shares or securities representing fractional shares of Common Stock,
the Company shall pay the holder in cash the fair value of fractions of a share
as of the date of conversion as determined by the Company’s board of directors.
For these purposes, the “date of conversion” shall mean the date the
Corporation receives a written notice of a voluntary conversion by the holder
or the date of automatic conversion pursuant to Section 4(A), above.

          C. The
Company covenants that it will at all times reserve and keep available, free
from preemptive rights, out of the aggregate of its authorized but unissued
shares of Common Stock or its issued shares of Common Stock held by its
treasury, or both, for the purpose of effective conversions of the Series B
Preferred Stock, the full number of shares of Common Stock deliverable upon the
conversion of all outstanding shares of the Series B Preferred Stock not
theretofore converted. For purposes of this Section 4(C), the number of shares
of Common Stock that shall be deliverable upon the conversion of all
outstanding 

- 3 -

shares of the Series B Preferred Stock shall be computed as if at the
time of computation all the outstanding shares were held by a single holder.

D. Adjustments of Conversion
Rate.

          (i) Adjustments
for Stock Splits and Combinations. If the Company shall, at any time or
from time to time after the date of issuance of the Series B Preferred Stock
(“Issuance Date”), effect a split of the outstanding Common Stock, the
Conversion Rate shall be proportionately adjusted. If the Company shall, at any
time or from time to time after the Issuance Date, combine the outstanding
shares of Common Stock, the Conversion Rate shall be proportionately adjusted.
Any adjustments under this Section 4(D)(i) shall be effective at the close of
business on the date the stock split or combination becomes effective.

          (ii) Adjustments
for Certain Dividends and Distributions. If the Company shall, at any time
or from time to time after the Issuance Date, make or issue or set a record
date for the determination of holders of Common Stock entitled to receive a
dividend or other distribution payable in shares of Common Stock, then, and in
each event, the Conversion Rate shall be adjusted as of the time of such
issuance or, in the event such record date shall have been fixed, as of the
close of business on such record date, by multiplying the Conversion Price then
in effect by a fraction:

                    a.
the numerator of which shall be the total number of shares of Common Stock
issued and outstanding immediately prior to the time of such issuance or the
close of business on such record date; and

                    b.
the denominator of which shall be the total number of shares of Common Stock
issued and outstanding immediately prior to the time of such issuance or the
close of business on such record date plus the number of shares of Common Stock
issuable in payment of such dividend or Distribution.

          (iii) Adjustment
for Other Dividends and Distributions. If the Company shall, at any time or
from time to time after the Issuance Date, make or issue or set a record date
for the determination of holders of Common Stock entitled to receive a dividend
or other Distribution payable in securities of the Company other than shares of
Common Stock, then, and in each event, an appropriate revision to the
applicable Conversion Rate shall be made and provision shall be made (by
adjustments of the Conversion Rate or otherwise) so that the Series B Preferred
Stockholders shall receive upon conversions thereof, in addition to the number
of shares of Common Stock receivable thereon, the number of securities of the
Company which they would have received had their shares of Series B Preferred
Stock been converted into Common Stock on the date of such event and had such
holder thereafter, during the period from the date of such event to and
including the Conversion Date, retained such securities (together with any
distributions payable thereon during such period), giving application to all
adjustments called for during such period under this Section 4(D)(iii) with
respect to the rights of the holders of the Series B Preferred Stock; provided,
however, that if such record date shall have been fixed and such dividend is 

- 4 -

not fully paid or if such distribution is
not fully made on the date
fixed therefor, the Conversion Rate shall be adjusted pursuant to this
paragraph as of the time of actual payment of such dividends or Distributions;
and provided further, however, that no such adjustment shall be made if the
holders of the Series B Preferred Stock simultaneously receive a dividend or
other distribution of shares of Common Stock in a number equal to the number of
shares of Common Stock as they would have received if all outstanding shares of
Series B Preferred Stock had been converted into Common Stock on the date of
such event.

          (iv) Adjustments
for Reclassification, Exchange or Substitution. If the Common Stock
issuable upon conversion of the Series B Preferred Stock at any time or from
time to time after the Issuance Date shall be changed to the same or different
number of shares of any class or classes of stock, whether by reclassification,
exchange, substitution or otherwise (other than by way of a stock split or
combination of shares or stock dividends provided for in Sections 4(D)(i), (ii)
and (iii), or a reorganization, merger, consolidation, or sale of assets
provided for in Section 4(D)(v), then, and in each event, an appropriate
revision to the Conversion Rate shall be made and provisions shall be made (by
adjustments of the Conversion Rate or otherwise) so that the holders of Series
B Preferred Stock shall have the right thereafter to convert their shares of
Series B Preferred Stock into the kind and amount of shares of stock and other
securities receivable upon reclassification, exchange, substitution or other change,
by holders of the number of shares of Common Stock into which such shares of
Series B Preferred Stock might have been converted immediately prior to such
reclassification, exchange, substitution or other change, all subject to
further adjustment as provided herein.

          (v) Adjustments
for Reorganization, Merger, Consolidation or Sales of Assets. If at any
time or from time to time after the Issuance Date there shall be a capital
reorganization of the Company (other than by way of a stock split or
combination of shares or stock dividends or Distributions provided for in
Section 4(D)(i), (ii) and (iii), or a reclassification, exchange or
substitution of shares provided for in Section 4(D)(iv)), or a merger or
consolidation of the Company with or into another corporation where the holders
of the Company’s outstanding voting securities prior to such merger or
consolidation do not own over 50% of the outstanding voting securities of the
merged or consolidated entity, immediately after such merger or consolidation,
or the sale of all or substantially all of the Company’s properties or assets
to any other person (an “Organic Change”), then as a part of such Organic
Change an appropriate revision to the Conversion Rate shall be made if
necessary and provision shall be made if necessary (by adjustments of the
Conversion Rate or otherwise) so that the holders of the shares of Series B
Preferred Stock shall have the right thereafter to convert their shares of
Series B Preferred Stock into the kind and amount of shares of stock and other
securities or property of the Company or any successor corporation resulting
from Organic Change. In any such case, appropriate adjustment shall be made in
the application of the provisions of this Section 4(D)(v) with respect to the
rights of the holders of shares of Series B Preferred Stock after the Organic
Change to the end that the provisions of this Section 4(D)(v) (including any
adjustment in the Conversion Rate then in effect and the number of shares of
stock or 

- 5 -

other securities deliverable upon
conversion of the Series B Preferred
Stock) shall be applied after that event in as nearly an equivalent manner as
may be practicable.

          (vi) Consideration
for Stock. In case any shares of Common Stock or Convertible Securities
other than the Series B Preferred Stock, or any rights or warrants or options
to purchase any such Common Stock or Convertible Securities, shall be issued or
sold:

                    a.
in connection with any merger or consolidation in which the Company is the
surviving corporation (other than any consolidation or merger in which the
previously outstanding shares of Common Stock of the Company shall be changed
to or exchanged for the stock or other securities of another corporation), the
amount of consideration therefore shall be deemed to be the fair value, as
determined reasonably and in good faith by the Board of Directors of the
Company, of such portion of the assets and business of the non-surviving
corporation as such Board may determine to be attributable to such shares of
Common Stock, Convertible Securities, rights or warrants or options, as the
case may be; or

                    b.
in the event of any consolidation or merger of the Company in which the Company
is not the surviving corporation or in which the previously outstanding shares
of Common Stock of the Company shall be changed into or exchanged for the stock
or other securities of another corporation, or in the event of any sale of all
or substantially all of the assets of the Company for stock or other securities
of any corporation, the Company shall be deemed to have issued a number of
shares of its Common Stock for stock or securities or other property of the
other corporation computed on the basis of the actual exchange ratio on which
the transaction was predicated, and for a consideration equal to the fair
market value on the date of such transaction of all such stock or securities or
other property of the other corporation. If any such calculation results in
adjustment of the applicable Conversion Rate, or the number of shares of Common
Stock issuable upon conversion of the Series B Preferred Stock, the
determination of the applicable Conversion Rate or the number of shares of
Common Stock issuable upon conversion of the Series B Preferred Stock
immediately prior to such merger, consolidation or sale, shall be made after
giving effect to such adjustment of the number of shares of Common Stock
issuable upon conversion of the Series B Preferred Stock. In the event any
consideration received by the Company for any securities consists of property
other than cash, the fair market value thereof at the time of issuance or as
otherwise applicable shall be as determined in good faith by the Board of
Directors of the Company. In the event Common Stock is issued with other shares
or securities or other assets of the Company for consideration which covers
both, the consideration computed as provided in this Section 4(D)(vi)(b) shall
be allocated among such securities and assets as determined in good faith by
the Board of Directors of the Company.

          (vii) No
Impairment. The Company shall not, by amendment of its Certificate of
Incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary 

- 6 -

action, avoid or seek to avoid the
observance or performance of any of
the terms to be observed or performed hereunder by the Company, but will at all
times in good faith assist in the carrying out of all the provisions of this
Section 4(E) and in the taking of all such action as may be necessary or
appropriate in order to protect the conversion rights of the holders of Series
B Preferred Stock against impairment. In the event any holder of Series B Preferred
Stock shall elect to convert any shares of Series B Preferred Stock as provided
herein, the Company cannot refuse conversion based on any claim that such
holder or anyone associated or affiliated with such holder has been engaged in
any violation of law, unless (i) the Company receives an order from the
Securities and Exchange Commission prohibiting such conversion or (ii) an
injunction from a court, on notice, restraining and/or enjoining conversion of
all or of said shares of Series B Preferred Stock shall have been issued.

          (viii) Certificates
as to Adjustments. Upon occurrence of each adjustment or readjustment of
the Conversion Rate or number of shares of Common Stock issuable upon
conversion of shares of Series B Preferred Stock pursuant to this Section 4(D),
the Company at its expense shall promptly compute such adjustment or
readjustment in accordance with the terms hereof and furnish to each holder of
shares of Series B Preferred Stock a certificate setting forth such adjustment
and readjustment, showing in detail the facts upon which such adjustment or
readjustment is based. The Company shall, upon written request of the holder of
such affected Series B Preferred Stock, at any time, furnish or cause to be
furnished to such holder a like certificate setting forth such adjustments and
readjustments, the Conversion Rate in effect at the time, and the number of
shares of Common Stock and the amount, if any, of other securities or property
which at the time would be received upon the conversion of the shares of Series
B Preferred Stock. Notwithstanding the foregoing, the Company shall not be
obligated to deliver a certificate unless such certificate would reflect an
increase or decrease of at least one percent of such adjusted amount.

5. Redemption.

          (A) The
Corporation shall have the right, following the anniversary date of the
issuance of the Series B Preferred Stock, to redeem the Series B Preferred
Stock, plus any accrued and unpaid dividends, in whole or in part, at any time
or from time to time (the “Redemption”), at a cash redemption price equal to
the greater of the Stated Value of the Series B Preferred Stock being redeemed
(the “Redemption Amount”) plus an amount equal to the amount of the accrued and
unpaid dividend thereon. In the event that fewer than all the outstanding
Series B Preferred Stock are to be redeemed, the number of Series B Preferred
Stock to be redeemed shall be determined by the Board of Directors, and the
shares to be redeemed shall be determined by lot or pro rata as may be determined by the Board of Directors or
by any other method as may be determined by the Board of Directors, in its sole
discretion to be equitable, provided that such method satisfies any applicable
requirements of any securities exchange (if any) on which the Series B
Preferred Stock are then listed. In the event the Corporation elects to redeem
the Series B Preferred Stock on or before the second anniversary of the
Closing, the Corporation shall deliver a written notice to the Holder of the
Series B Preferred Stock at the Holder’s last known address as set forth in the
Series B Preferred Stock Register, advising the Holder of the Redemption (the “
Redemption Notice”). Upon delivery 

- 7 -

by the Company of the Redemption Notice, the Holder shall have ten (10)
days to convert all, but not less than all, of the Series B Preferred Stock,
plus the amount of the accrued and unpaid dividend thereon , into a number of
shares of Common Stock equal to the number of shares of the Series B Preferred
Stock converted by the Holder plus any accrued and unpaid dividends divided by
the Conversion Rate. In such instance, the Series B shall be converted pursuant
to the mechanics set forth in Section 4 above.

          (B) The
Corporation shall not redeem or set aside funds for the redemption of any stock
of the Corporation ranking on parity with the Series B Preferred Stock as to
dividends or amounts upon liquidation unless prior to or contemporaneously
therewith it redeems, or sets aside funds for the redemption of, a number of
shares of Series B Preferred Stock whose liquidation preference bears the same
relationship to the aggregate liquidation preference of all shares of Series B
Preferred Stock then outstanding as the liquidation preference of such parity
stock to be redeemed bears to the aggregate liquidation preference of all
parity stock then outstanding. 

6. Voting. 

Except as otherwise provided herein or required by law, the holders of
the Series B Preferred Stock shall be entitled to vote together as a single
class with the holders of Common Stock and any other capital stock of the
Corporation entitled to vote, upon any matter submitted to the stockholders for
a vote. The holders of Series B Preferred Stock shall be entitled to cast a
number of votes calculated as if the shares of Series B Preferred Stock had
been converted into shares of Common Stock based on the Conversion Rate.

7. Waiver by Series B Preferred Stockholders.

Except as expressly provided for herein or as otherwise required by
law, any rights or benefits for the Series B Preferred Shares and the holders
thereof provided herein may only be waived as to all outstanding Series B
Preferred Shares by the affirmative written consent of the holders of all of
the shares of then-outstanding Series B Preferred Stock.

8. Additional Issuance of Preferred Shares. 

The Company may issue additional shares of Preferred Stock in the
future. If the Company desires to issue additional shares of Preferred Stock,
the Company shall file such amendments to its Certificate of Incorporation as
may be necessary to effect such designation.

 (The rest of this page left intentionally
blank.)

- 8 -

          IN WITNESS WHEREOF,
the Company has caused
this Certificate of Designation to be duly executed by its President and
attested to by its Secretary as of the 21st day of December, 2009, who, by
signing their names hereto, acknowledge that this Certificate of Designation is
the act of the Company and state to the best of their knowledge, information
and belief, under penalties of perjury, that the above matters and facts are
true in all material respects.

	
  

 	
  

 	
  

 
	
 VYCOR
 MEDICAL, INC.

 
	
  

 
	
 /s/ Heather C. Vinas

 
	
 By:

 
	
  

 	 

 	
  

 
	
  

 	
 Name:
 Heather C. Vinas

 	
  

 
	
  

 	
 Title:
 President

 	
  

 
	
  

 
	
 /s/ Kenneth T.
Coviello

 
	
 By:

 
	
  

 	 

 	
  

 
	
  

 	
 Name:
 Kenneth T. Coviello

 	
  

 
	
  

 	
 Title:
 Secretary

 	
  

 

- 9 -Fountainhead Capital Management Limited

December 29,
2009

Vycor Medical,
Inc.

80 Orville Drive, Suite 100

Bohemia, New York 11716

	
  

 	
  

 	
  

 
	
  

 	
 Re:

 	
 Waiver of
 (1) Anti-Dilution Rights with respect to Warrant dated December 15, 2006 and
 (2) Default on Debentures

 

Ladies and
Gentlemen:

The purpose of
this letter agreement is to confirm the following agreements by Fountainhead
Capital Management Limited (“FCM”) relative to the matters detailed below

Waiver of
Anti-Dilution Rights with respct to Warrant Dated December 15, 2006:

On December
15, 2006, Vycor Medical, LLC issued a Warrant (“Warrant”) to FCM’s predecessor,
Fountainhead Capital Partners Limited, to purchase 50.22 units Vycor Medical,
LLC at an exercise price of $7,965 per unit. Thereafter, Vycor was converted into
a Delaware corporation, Vycor Medical, Inc. (“Vycor”) and the Warrant
thereafter became exercisable as to 805,931 shares $.50 per share. Effective
February 15, 2008, Fountainhead Capital Partners Limited assigned its interest
in the Warrant to FCM which assigned one-half of its interest in the Warrant to
Regent Private Capital, LLC (“Regent”).

The Warrant
contained certain anti-dilution provisions in paragraph 6 thereof which
provided for adjustments of the number of warrants upon the occurrence of certain
events. By letter agreement dated as of December 21, 2009, FCM agreed to a
series of transactions as a part of a restructuring of its and Regent’s
relationship with Vycor, including but not limited to an exchange of certain
Debentures for common shares of Vycor (the “Restructuring”).

By this
letter, FHC confirms that it is waiving any and all of the anti-dilution
provisions in paragraph 6 of the Warrant as such may be applicable to the
various transactions comprising the Restructuring. Such waiver shall not be
effective to any other events detailed in such anti-dilution provisions other
than those actions which are specifically related to the Restructuring, and in
particular does not affect the price-adjustment provisions of paragraph 11 of
the Warrant.

Default on
Debentures:

Vycor is in
default on certain of its obligations related to certain Debentures issued by
Vycor to FHC. As a result of the Restructuring, the maturity dates of all such
Debentures are extended to August 30, 2009 and certain other defaults with
respect thereto have been cured. 

Vycor Medical,
Inc.

December 29, 2009

Page 2

FHC hereby
advises Vycor that as of the closing of the Restructuring, Vycor will not be in
default of any provisions of said Debentures. 

By this
letter, FHC confirms that it rescinds any notices of default previously issued
on account of said Debentures and waives its right to take any action with
respect to any default thereon which may have occurred prior to the date of
this letter. Nothing in this letter shall be deemed to waive any default by
Vycor which may occur after the date of this letter.

In all other
respects, other than as specifically modified in connection with the
Restructuring, all other rights and remedies FHC may have with respect to any
aspect of its relationship with Vycor shall remain unchanged.

Sincerely,

	
  

 	
  

 	
  

 
	
 FOUNTAINHEAD
 CAPITAL MANAGEMENT LIMITED

 	
  

 
	
  

 	
  

 
	
  

 	
 /s/ Gisele Le Miere, Director

 	
  

 
	
 By:

 	
 ____________________________

 	
  

 
	
  

 	
  

 	
  

 
	
  

 	
  

 	
  

 
	
  

 	
 /s/ Carole Dodge, Director

 	
  

 
	
 By:

 	
 ____________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}]]